Your browser doesn't support javascript.
loading
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma.
Jethava, Y; Mitchell, A; Zangari, M; Waheed, S; Schinke, C; Thanendrarajan, S; Sawyer, J; Alapat, D; Tian, E; Stein, C; Khan, R; Heuck, C J; Petty, N; Avery, D; Steward, D; Smith, R; Bailey, C; Epstein, J; Yaccoby, S; Hoering, A; Crowley, J; Morgan, G; Barlogie, B; van Rhee, F.
Afiliação
  • Jethava Y; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Mitchell A; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Zangari M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Waheed S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Schinke C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Thanendrarajan S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Sawyer J; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Alapat D; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Tian E; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Stein C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Khan R; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Heuck CJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Petty N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Avery D; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Steward D; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Smith R; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bailey C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Epstein J; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Yaccoby S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Hoering A; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Crowley J; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Morgan G; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • van Rhee F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Blood Cancer J ; 6(7): e453, 2016 07 29.
Article em En | MEDLINE | ID: mdl-27471869
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Perfilação da Expressão Gênica / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Perfilação da Expressão Gênica / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos